Aerolib AI Launches Platform to Automate Healthcare Appeals and Recover Billions in Denied Revenue
A new AI-powered solution aims to drastically improve appeal success rates and reduce administrative burdens for hospitals facing mounting claim denials.
Hospitals lose billions of dollars annually due to denied claims, a challenge Aerolib Healthcare Solutions is addressing with the launch of Aerolib AI. The new platform is designed to automate and enhance the healthcare appeals process, promising to transform compliance, utilization management, and medical necessity support.
According to a company release, Aerolib AI is “turning the tide by bringing intelligent automation, clinical insight, and measurable ROI to revenue cycle teams.” The platform leverages artificial intelligence to streamline a historically complex and resource-intensive process.
At the heart of Aerolib AI is its AI-driven denial analysis, which utilizes natural language processing to pinpoint the root causes, patterns, and clinical justifications behind claim rejections. This allows the system to generate physician-reviewed, evidence-based appeal letters in a matter of minutes, a significant improvement over the days or weeks traditionally required.
The platform doesn’t simply generate letters, however. Aerolib AI also features a scoring system that assesses and ranks the likelihood of an appeal’s success before submission, allowing hospitals to prioritize their efforts. Furthermore, an integrated learning management system (LMS) provides ongoing education to physician advisors and hospital staff through on-demand video modules, ensuring best practices are consistently applied.
Aerolib AI is built on a cloud-based, scalable infrastructure, ensuring enterprise-grade security, high availability, and rapid deployment without the need for costly on-premise infrastructure. Its compatibility with both PDFs and structured files simplifies onboarding, as integration with existing Electronic Medical Record (EMR) systems is not required.
Early adopters of the Aerolib AI solution have reported impressive results. Hospitals utilizing the platform have seen an average appeal success rate of 75%, reclaiming millions in previously lost revenue and reducing administrative workload by up to 60%.
“We don’t just write appeal letters — we deliver a complete clinical ROI engine that empowers hospitals to defend patient care decisions with confidence and speed,” stated Dr. Deepak Pahuja, chief medical officer and founder of Aerolib.
Aerolib AI is a key component of the broader Aerolib Ecosystem, which also includes physician advisor services and process improvement pilots. Organizations can evaluate the platform’s impact firsthand through a 30-day pilot program, requiring no long-term commitment.
